PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 213 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $952,062 | -54.3% | 31,032 | -40.3% | 0.01% | -50.0% |
| Q2 2023 | $2,083,039 | +5.1% | 51,985 | +7.0% | 0.02% | -5.9% |
| Q1 2023 | $1,982,591 | +104467.0% | 48,581 | -1.1% | 0.02% | +6.2% |
| Q4 2022 | $1,896 | -99.9% | 49,104 | +17.6% | 0.02% | -27.3% |
| Q3 2022 | $2,221,000 | -8.0% | 41,751 | +0.8% | 0.02% | -15.4% |
| Q2 2022 | $2,415,000 | -17.6% | 41,420 | +7.9% | 0.03% | -10.3% |
| Q1 2022 | $2,931,000 | +44.7% | 38,401 | +14.1% | 0.03% | +38.1% |
| Q4 2021 | $2,026,000 | +7.3% | 33,666 | -0.1% | 0.02% | -4.5% |
| Q3 2021 | $1,888,000 | -7.9% | 33,706 | -0.2% | 0.02% | -4.3% |
| Q2 2021 | $2,050,000 | -13.5% | 33,785 | -0.1% | 0.02% | -20.7% |
| Q1 2021 | $2,371,000 | +17.7% | 33,827 | +0.5% | 0.03% | +3.6% |
| Q4 2020 | $2,014,000 | +1.0% | 33,654 | +1.5% | 0.03% | -28.2% |
| Q3 2020 | $1,994,000 | +79.2% | 33,167 | +56.4% | 0.04% | +85.7% |
| Q2 2020 | $1,113,000 | +58.1% | 21,203 | +1.0% | 0.02% | +31.2% |
| Q1 2020 | $704,000 | +9.8% | 20,996 | +48.4% | 0.02% | +45.5% |
| Q4 2019 | $641,000 | +19.1% | 14,148 | +0.2% | 0.01% | +10.0% |
| Q3 2019 | $538,000 | -64.1% | 14,122 | -8.6% | 0.01% | -54.5% |
| Q3 2014 | $1,497,000 | +5.1% | 15,450 | -0.4% | 0.02% | +4.8% |
| Q2 2014 | $1,424,000 | +31.2% | 15,505 | 0.0% | 0.02% | +23.5% |
| Q1 2014 | $1,085,000 | +21.8% | 15,505 | 0.0% | 0.02% | +21.4% |
| Q4 2013 | $891,000 | -12.3% | 15,505 | -26.6% | 0.01% | -17.6% |
| Q3 2013 | $1,016,000 | – | 21,130 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |